{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:47:51Z","timestamp":1791287271903,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001934","type":"journal-article","created":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T18:58:26Z","timestamp":1452020306000},"page":"e1001934","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial"],"prefix":"10.1371","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct01425073","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Christina S.","family":"Polyak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Yuhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Singa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Khaemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judd","family":"Walson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","article-title":"Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C\u00f4te d\u2019Ivoire: a randomised trial","volume":"353","author":"X Anglaret","year":"1999","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(99)03465-0","article-title":"Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, C\u00f4te d\u2019Ivoire: a randomised controlled trial","volume":"353","author":"SZ Wiktor","year":"1999","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(06)68541-3","article-title":"Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study","volume":"367","author":"J Mermin","year":"2006","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4269\/ajtmh.2008.79.320","article-title":"Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?","volume":"79","author":"MJ Hamel","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00002030-200106150-00009","article-title":"Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO\/UNAIDS recommendations","volume":"15","author":"M Badri","year":"2001","journal-title":"AIDS"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"128C","DOI":"10.2471\/BLT.11.093260","article-title":"Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis","volume":"90","author":"AB Suthar","year":"2012","journal-title":"Bull World Health Organ"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","article-title":"Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomized placebo-controlled trial","volume":"364","author":"C Chintu","year":"2004","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0b013e3181378ed2","article-title":"Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi","volume":"46","author":"D Lowrance","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1214901","article-title":"A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa","volume":"370","author":"M Bwakura-Dangarembizi","year":"2014","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cis013","article-title":"HIV-infected Ugandan adults taking antiretroviral therapy with CD4 counts >200 cells\/L who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea","volume":"54","author":"JD Campbell","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(10)60057-8","article-title":"Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort","volume":"375","author":"AS Walker","year":"2010","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1097\/00002030-199909100-00012","article-title":"Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis","volume":"13","author":"AD McNaghten","year":"1999","journal-title":"AIDS"},{"key":"ref13","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"JE Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"ref14","article-title":"Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: recommendations for a public health approach","year":"2006"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy","volume":"340","author":"H Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection","volume":"353","author":"GJ Weverling","year":"1999","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/655761","article-title":"Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells\/microL?","volume":"51","author":"A Mocroft","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref18","article-title":"December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","year":"2014"},{"key":"ref19","article-title":"Guidelines for antiretroviral therapy in Kenya","year":"2011"},{"key":"ref20","article-title":"National manual for the management of HIV-related opportunistic infections and conditions","year":"2011"},{"key":"ref21","article-title":"Division of AIDS table for grading the severity of adult and pediatric adverse events","year":"2004"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2012.87802","article-title":"Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement","volume":"308","author":"G Piaggio","year":"2012","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/QAI.0b013e318141fcc0","article-title":"Morbidity among HIV-1-infected mothers in Kenya: prevalence and correlates of illness during 2-year postpartum follow-up","volume":"46","author":"JL Walson","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0021-9681(81)90007-2","article-title":"Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation","volume":"34","author":"LV Rubinstein","year":"1981","journal-title":"J Chronic Dis"},{"key":"ref25","article-title":"Stata 12","year":"2011"},{"key":"ref26","unstructured":"Polyak CS, Yuhas K, Singa B, Khaemba M, Walson J, et al. (2014) CTX discontinuation among ART-treated adults: a randomized non-inferiority trial [abstact]. Conference on Retroviruses and Opportunistic Infections; 3\u20136 Mar 2014; Boston, MA, US."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0140-6736(91)91299-A","article-title":"Co-trimoxazole for childhood febrile illness in malaria-endemic regions","volume":"337","author":"PB Bloland","year":"1991","journal-title":"Lancet"},{"key":"ref28","article-title":"HIV and AIDS profile: Homa Bay County","year":"2012"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.13-0552","article-title":"Water filter provision and home-based filter reinforcement reduce diarrhea in Kenyan HIV-infected adults and their household members","volume":"91","author":"PB Pavlinac","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","article-title":"Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda","volume":"364","author":"J Mermin","year":"2004","journal-title":"Lancet"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T23:09:35Z","timestamp":1654038575000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001934"}},"subtitle":[],"editor":[{"given":"Andrew","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,1,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001934","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,5]]}}}